top of page
Home
More
Use tab to navigate through the menu items.
To see this working, head to your live site.
Categories
All Posts
My Posts
Untitled Category
Welcome! Have a look around and join the conversations.
AT Biomanufacturing Updates
Sort by:
Â
Recent Activity
Follow Category
Create New Post
Bryan Kennedy
July AT Biomanufacturing Recap...
CDMO Expansions: • SEQENS has entered into exclusive negotiations with Novartis for the potential acquisition of the French company Cellforcure and its cell & gene therapy development and production site. CELLforCURE’s has large-scale industrial production of cell & gene therapies. With over 10,00
0 comments
0
Aug 21, 2023
Like
0 comments
Comment
Bryan Kennedy
AT Biomanufacturing Update, July 2023
CDMO Expansions: • SEQENS has entered into exclusive negotiations with Novartis for the potential acquisition of the French company Cellforcure and its cell & gene therapy development and production site. CELLforCURE’s has large-scale industrial production of cell & gene therapies. With over 10,00
0 comments
0
Aug 22, 2023
Like
0 comments
Comment
Bryan Kennedy
The U.S. AT CDMO Update
Facility and Expansions • MilliporeSigma Invests $25M to Expand Cell Culture Media Production in Kansas by 98,000sf. Cell culture media is an essential raw material used in the manufacture of therapies and in processes for vaccines, gene therapy, and mAb manufacturing. (genengnews) • Lonza and Ve
0 comments
0
Sep 21, 2023
Like
0 comments
Comment
Forum: Forum
The Berke Report
Start Now
bottom of page
G-86H057MJFZ
